A phase I study of EC0225 administered weeks 1 and 2 of a 4-week cycle.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. Sharma, E. A. Sausville, P. LoRusso, N. J. Vogelzang, W. E. Samlowski, J. Carter, K. Forman, S. Bever, R. A. Messmann
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2341670115
